微巨實(shí)業(yè)是一家以研發(fā)，生產(chǎn)和銷(xiāo)售一體的科技公司。公司與業(yè)內多家知名藥企達成戰略合作，致力于為客戶(hù)提供優(yōu)質(zhì)的產(chǎn)品和專(zhuān)業(yè)的服務(wù)，可接受客戶(hù)的供應商審計需求。

技術(shù)創(chuàng )新，建立競爭優(yōu)勢;專(zhuān)業(yè)服務(wù)創(chuàng )造顧客價(jià)值。

我們產(chǎn)品管線(xiàn)專(zhuān)注于以下領(lǐng)域的藥物：

1核糖核苷衍生物在抗腫瘤、抗病毒領(lǐng)域；

2神經(jīng)系統疾病藥物

3高血壓、糖尿病藥物

4 生物醫藥領(lǐng)域中間體產(chǎn)品

加強自主創(chuàng )新能力和持續投資，是提高我們核心競爭力的關(guān)鍵性戰略之一。

愿與所有客戶(hù)攜手合作，共同成長(cháng)

Micro-mega is a based the research and development and innovation-driven company. We are committed to provide best quality product and professional service to meet customer require. Technology Innovation Establish Competitive Advantage and Professional Service Create Customer’s Value.

In the pharmaceutical industry, we focus on the following drugs:

1 The Ribose and Nucleoside Derivatives in the field of anti-cancer and anti-viral;

2 The Nervous System disease drugs

3 The Hypertension, Diabetes drugs

4 Biological medicine field of intermediate products

It is one of key strategies of us to improve our core competition ability by strengthening the independent innovation capability and continuous investment. We wish to cooperate with all customers and grow together.